UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms for the transition from physiological to pathological cardiac hypertrophy

Canadian journal of physiology and pharmacology, 2020-02, Vol.98 (2), p.74-84

2020

Volltextzugriff (PDF)

Long non‐coding RNA cardiac hypertrophy‐associated regulator governs cardiac hypertrophy via regulating miR‐20b and the downstream PTEN/AKT pathway

Journal of cellular and molecular medicine, 2019-11, Vol.23 (11), p.7685-7698

2019

Volltextzugriff (PDF)

Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies

Pharmacology & therapeutics (Oxford), 2010-10, Vol.128 (1), p.191-227

2010

Volltextzugriff (PDF)

Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure

Canadian journal of physiology and pharmacology, 2024-02, Vol.102 (2), p.86-104

2024

Volltextzugriff (PDF)

Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis

Proceedings of the National Academy of Sciences - PNAS, 2015-07, Vol.112 (29), p.9046-9051

2015

Volltextzugriff (PDF)

Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure

Reviews in cardiovascular medicine, 2023-09, Vol.24 (9), p.264

2023

Volltextzugriff (PDF)

Gender Differences in Cardiac Hypertrophy

Journal of cardiovascular translational research, 2020-02, Vol.13 (1), p.73-84

2020

Volltextzugriff (PDF)

MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats

Physiological genomics, 2011-06, Vol.43 (11), p.665-673

2011

Volltextzugriff (PDF)

Zinc rescues obesity‐induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress‐activated BCL10/CARD9/p38 MAPK pathway

Journal of cellular and molecular medicine, 2017-06, Vol.21 (6), p.1182-1192

2017

Volltextzugriff (PDF)

Noncoding RNAs in Cardiac Hypertrophy

Journal of cardiovascular translational research, 2018-12, Vol.11 (6), p.439-449

2018

Volltextzugriff (PDF)

Formononetin alleviates diabetic cardiomyopathy by inhibiting oxidative stress and upregulating SIRT1 in rats

Asian Pacific journal of tropical biomedicine, 2020-06, Vol.10 (6), p.254-262

2020

Volltextzugriff (PDF)

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII

Oncotarget, 2017-07, Vol.8 (29), p.47565-47573

2017

Volltextzugriff (PDF)

Alcohol-induced histone H3K9 hyperacetylation and cardiac hypertrophy are reversed by a histone acetylases inhibitor anacardic acid in developing murine hearts

Biochimie, 2015-06, Vol.113, p.1-9

2015

Volltextzugriff (PDF)

Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy

Chinese medical journal, 2018-10, Vol.131 (19), p.2287-2296

2018

Volltextzugriff (PDF)

Calcific Aortic Valve Disease: Part 2—Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility

Journal of cardiovascular translational research, 2016-08, Vol.9 (4), p.374-399

Pasipoularides, Ares

2016

Volltextzugriff (PDF)

NLRX1 attenuates endoplasmic reticulum stress via STING in cardiac hypertrophy

Biochimica et biophysica acta. Molecular cell research, 2024-12, Vol.1871 (8), p.119852, Article 119852

2024

Volltextzugriff (PDF)

Abstract 1808 Loss of Mitochondrial NAD+ Transporter SLC25A51 in Cardiomyocytes Impairs Complex I Respiration and Induces Cardiac Hypertrophy

The Journal of biological chemistry, 2024-03, Vol.300 (3), p.106689, Article 106689

2024

Volltextzugriff (PDF)

Molecular Basis of Cardiovascular Diseases : Implications of Natriuretic Peptides

2019

Volltextzugriff (PDF)

Exercise in ozone-polluted air evokes pathological cardiac hypertrophy via up-regulation of nuclear lncRNA EYA4-au1 and recruiting Med11 to activating EYA4/p27kip1/CK2α/HDAC2 cascade

Ecotoxicology and environmental safety, 2024-10, Vol.287, p.117264, Article 117264

2024

Volltextzugriff (PDF)

SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy

European journal of pharmacology, 2022-09, Vol.930, p.175155-175155, Article 175155

2022

Volltextzugriff (PDF)

Deoxyelephantopin—a novel PPARγ agonist regresses pressure overload-induced cardiac fibrosis via IL-6/STAT-3 pathway in crosstalk with PKCδ

European journal of pharmacology, 2023-08, Vol.953, p.175841-175841, Article 175841

2023

Volltextzugriff (PDF)

Extracellular vesicular MicroRNA-27a contributes to cardiac hypertrophy in chronic heart failure

Journal of molecular and cellular cardiology, 2020-06, Vol.143, p.120-131

2020

Volltextzugriff (PDF)

NDRG1 regulates iron metabolism and inhibits pathological cardiac hypertrophy

Canadian journal of cardiology, 2024-10

2024

Volltextzugriff (PDF)

Changes in short‐chain acyl‐coA dehydrogenase during rat cardiac development and stress

Journal of cellular and molecular medicine, 2015-07, Vol.19 (7), p.1672-1688

2015

Volltextzugriff (PDF)

A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223

European heart journal, 2016-09, Vol.37 (33), p.2602-2611

2016

Volltextzugriff (PDF)

1 – 25 von 20.748

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19.569)
Mit Volltextzugriff
(18.919)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(18.527)
Life Sciences & Biomedicine
(18.015)
Cardiovascular System & Cardiology
(12.468)
Cardiac & Cardiovascular Systems
(11.619)
Humans
(10.402)
Male
(9.761)
Animals
(9.105)
Hypertrophy
(7.431)
Female
(6.208)
Heart
(4.843)
Cardiac Hypertrophy
(4.766)
Biological And Medical Sciences
(4.719)
Rats
(4.614)
Medical Sciences
(4.358)
Middle Aged
(4.068)
Echocardiography
(3.379)
Peripheral Vascular Disease
(3.309)
Cardiology. Vascular System
(3.216)
Heart Failure
(3.192)
Hypertrophy, Left Ventricular - Physiopathology
(3.155)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(17.282)
IngentaConnect
(12.922)
EZB Electronic Journals Library
(11.916)
Journals@Ovid Full Text
(9.738)
IngentaConnect Journals
(5.653)
Elsevier ScienceDirect Journals Complete
(4.924)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(3.527)
SpringerLink_现刊
(2.343)
Wiley-Blackwell Journals
(2.067)
Publisher or Other Site
(2.014)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.689)
Oxford Journals
(1.490)
Oxford Journals 2020 Medicine
(1.405)
Wiley Online Library Full Collection 2018
(1.251)
Taylor & Francis Journals
(493)
Nature - Journals : Nature ; Nature Climate Change
(423)
Taylor & Francis
(376)
Taylor & Francis Journals Complete
(344)
BMJ journals single titles
(300)
BMJ Journals Archiv - DFG Nationallizenzen
(250)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Mechanisms for the transition from physiological to pathological cardiac hypertrophy

Long non‐coding RNA cardiac hypertrophy‐associated regulator governs cardiac hypertrophy via regulating miR‐20b and the downstream PTEN/AKT pathway

Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies

Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure

Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis

Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure

Gender Differences in Cardiac Hypertrophy

MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats

Zinc rescues obesity‐induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress‐activated BCL10/CARD9/p38 MAPK pathway

Noncoding RNAs in Cardiac Hypertrophy

Formononetin alleviates diabetic cardiomyopathy by inhibiting oxidative stress and upregulating SIRT1 in rats

LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII

Alcohol-induced histone H3K9 hyperacetylation and cardiac hypertrophy are reversed by a histone acetylases inhibitor anacardic acid in developing murine hearts

Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-Induced Cardiac Hypertrophy

Calcific Aortic Valve Disease: Part 2—Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility

NLRX1 attenuates endoplasmic reticulum stress via STING in cardiac hypertrophy

Abstract 1808 Loss of Mitochondrial NAD+ Transporter SLC25A51 in Cardiomyocytes Impairs Complex I Respiration and Induces Cardiac Hypertrophy

Molecular Basis of Cardiovascular Diseases : Implications of Natriuretic Peptides

Exercise in ozone-polluted air evokes pathological cardiac hypertrophy via up-regulation of nuclear lncRNA EYA4-au1 and recruiting Med11 to activating EYA4/p27kip1/CK2α/HDAC2 cascade

SUMOylation of SIRT1 activating PGC-1α/PPARα pathway mediates the protective effect of LncRNA-MHRT in cardiac hypertrophy

Deoxyelephantopin—a novel PPARγ agonist regresses pressure overload-induced cardiac fibrosis via IL-6/STAT-3 pathway in crosstalk with PKCδ

Extracellular vesicular MicroRNA-27a contributes to cardiac hypertrophy in chronic heart failure

NDRG1 regulates iron metabolism and inhibits pathological cardiac hypertrophy

Changes in short‐chain acyl‐coA dehydrogenase during rat cardiac development and stress

A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223

Suchergebnisse filtern